Oncothyreon, Inc. (ONTY) Posts Q2 Loss of 91c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts ONTY Hot Sheet
Join SI Premium – FREE
Oncothyreon, Inc. (NASDAQ: ONTY) reported Q2 loss of ($0.91), $0.75 worse than the analyst estimate of ($0.16).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LTC Properties (LTC) Tops Q3 EPS by 22c
- InnovAge (INNV) Tops Q1 EPS by 6c; Offers Guidance
- Modine Manufacturing (MOD) Misses Q2 EPS by 7c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
